SAW

RF Acoustic Wave Filters Patent Landscape 2024: Global Patenting Trends and Coverage of 11,300, Patent Families

Retrieved on: 
Thursday, March 7, 2024

DUBLIN, March 7, 2024 /PRNewswire/ -- The "RF Acoustic Wave Filters - Patent Landscape 2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 7, 2024 /PRNewswire/ -- The "RF Acoustic Wave Filters - Patent Landscape 2024" report has been added to ResearchAndMarkets.com's offering.
  • The RF Acoustic Wave Filters Patent Landscape report aims to understand the current IP activities and how they can support the market strategies of players.
  • In this report, the analyst has manually selected more than 11,000 patent families (inventions) related to SAW filters, BAW filters, and multiplexers and RF front-end modules using them, and provide a general overview of today's IP landscape global trends and dynamics.
  • Global patenting trends, including time evolution of patent publications, countries of patent filings, etc.

Sanan IC premieres at MWC Barcelona to promote full turn-key RF front-end wafer foundry solution

Retrieved on: 
Wednesday, February 28, 2024

As the most influential worldwide telecommunications event, MWC Barcelona is regarded as the benchmark for the global mobile communications marketplace.

Key Points: 
  • As the most influential worldwide telecommunications event, MWC Barcelona is regarded as the benchmark for the global mobile communications marketplace.
  • Its main business is RF front-end IC wafer manufacturing, which includes GaAs (Gallium Arsenide) wafer foundry services, SAW filters, and advanced packaging for RF.
  • Sanan IC develops GaAs RF HBT and pHEMT technologies to support customers' designs in 4/5G frequency bands such as Sub-3G and Sub-6GHz.
  • Sanan IC will keep investing in technologies development, and improving the performance and reliability of services and products.

Sanan IC premieres at MWC Barcelona to promote full turn-key RF front-end wafer foundry solution

Retrieved on: 
Wednesday, February 28, 2024

As the most influential worldwide telecommunications event, MWC Barcelona is regarded as the benchmark for the global mobile communications marketplace.

Key Points: 
  • As the most influential worldwide telecommunications event, MWC Barcelona is regarded as the benchmark for the global mobile communications marketplace.
  • Its main business is RF front-end IC wafer manufacturing, which includes GaAs (Gallium Arsenide) wafer foundry services, SAW filters, and advanced packaging for RF.
  • Sanan IC develops GaAs RF HBT and pHEMT technologies to support customers' designs in 4/5G frequency bands such as Sub-3G and Sub-6GHz.
  • Sanan IC will keep investing in technologies development, and improving the performance and reliability of services and products.

Six Flags Magic Mountain Goes All Out with the Return of Scream Break Haunt and Flavors of the World Food Festival

Retrieved on: 
Thursday, February 15, 2024

Six Flags Magic Mountain , the undisputed Thrill Capital of the World, adds a dose of vitamin scream to Spring Break with the return of the guest-favorite haunt event, Scream Break, and culturally diverse food festival, Flavors of the World.

Key Points: 
  • Six Flags Magic Mountain , the undisputed Thrill Capital of the World, adds a dose of vitamin scream to Spring Break with the return of the guest-favorite haunt event, Scream Break, and culturally diverse food festival, Flavors of the World.
  • View the full release here: https://www.businesswire.com/news/home/20240215651768/en/
    Scream Break at Six Flags Magic Mountain adds a dose of vitamin SCREAM to Spring Break with haunted attractions, rides in the dark, festive foods and more!
  • For information on all events at Six Flags Magic Mountain, including Scream Break and Flavors of the World, visit sixflags.com/magicmountain/events .
  • Six Flags Magic Mountain is currently hiring all positions for Spring Break, plus Scream Break event-specific positions including monsters and scare actors.

NanoVibronix Featured in Your Bladder Health Magazine

Retrieved on: 
Wednesday, December 6, 2023

NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that its UroShield is featured in Issue 103 of Your Bladder Health Magazine in an article titled ‘UroShield Prevention is better than cure.’ The article highlights the effectiveness of using UroShield in the prevention of catheter associated urinary tract infections (CAUTIs).

Key Points: 
  • NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that its UroShield is featured in Issue 103 of Your Bladder Health Magazine in an article titled ‘UroShield Prevention is better than cure.’ The article highlights the effectiveness of using UroShield in the prevention of catheter associated urinary tract infections (CAUTIs).
  • The article also includes testimonials that detail the positive impact that UroShield has had on the lives of patients.
  • View the full release here: https://www.businesswire.com/news/home/20231206453100/en/
    Brian Murphy, Chief Executive Officer of NanoVibronix, Inc., said, “This article reinforces our efforts to raise market and clinician awareness, a key driver to accelerating adoption and increasing sales.
  • Thankfully UroShield addresses and solves all these serious concerns and has some additional benefits to users in reducing pain associated with catheter use, and a reduction in bladder spasms which some people suffer from.’

NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity

Retrieved on: 
Monday, December 4, 2023

NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has entered into a non-binding letter of intent (the “LOI”) with APOGEPHA Arzneimittel GmbH (“APOGEPHA”) in which both parties will analyze the potential for APOGEPHA to distribute NanoVibronix’s premiere UroShield product in Germany and other European markets.

Key Points: 
  • NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has entered into a non-binding letter of intent (the “LOI”) with APOGEPHA Arzneimittel GmbH (“APOGEPHA”) in which both parties will analyze the potential for APOGEPHA to distribute NanoVibronix’s premiere UroShield product in Germany and other European markets.
  • With a history that dates back over 100 years, APOGEPHA has established itself as a high quality, dedicated specialist in the field of urology.
  • Under the terms of the LOI, APOGEPHA will commence a comprehensive market evaluation on how UroShield fits into the pathway of care for patients with long term catheters.
  • The goal of the LOI, and subsequent findings, will be for both NanoVibronix and APOGEPHA to better understand the feasibility of a distribution deal between both companies.

NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan

Retrieved on: 
Tuesday, November 28, 2023

NanoVibronix, Inc. (Nasdaq: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has signed a Research Agreement with the Regents of the University of Michigan for a Randomized Control Trial (“RCT”) study of UroShield.

Key Points: 
  • NanoVibronix, Inc. (Nasdaq: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has signed a Research Agreement with the Regents of the University of Michigan for a Randomized Control Trial (“RCT”) study of UroShield.
  • Brian Murphy, Chief Executive Officer of NanoVibronix, Inc., said, “We are partnering with a team of distinguished researchers at the University of Michigan to further advance clinical evidence of the efficacy of UroShield.
  • The first phase of the study will include a validation pilot of 20 patients in advance of the full study.
  • We look forward to receiving the researchers’ conclusions and hope for positive outcomes for patients in the study.

NanoVibronix Regains Nasdaq Compliance

Retrieved on: 
Tuesday, November 21, 2023

NanoVibronix, Inc ., (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that on November 20, 2023, the Company received official notice from The Nasdaq Stock Market LLC that the Company has evidenced compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the minimum stockholders’ equity requirement of $2.5 million.

Key Points: 
  • NanoVibronix, Inc ., (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that on November 20, 2023, the Company received official notice from The Nasdaq Stock Market LLC that the Company has evidenced compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the minimum stockholders’ equity requirement of $2.5 million.
  • Accordingly, the previously disclosed listing matter has been closed.

NanoVibronix Issues Letter to Shareholders

Retrieved on: 
Tuesday, November 14, 2023

NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today issued a letter to shareholders from its Chief Executive Officer, Brian Murphy, providing a review of the third quarter 2023 and recent business developments.

Key Points: 
  • NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today issued a letter to shareholders from its Chief Executive Officer, Brian Murphy, providing a review of the third quarter 2023 and recent business developments.
  • We recorded revenues of $458,000 for the quarter ended September 30, 2023 with a loss from operations of $670,000.
  • In the relative year-to-date period, revenues increased 22% and the loss from operations was reduced by approximately 20%.
  • CMS invited NanoVibronix to a public meeting to present our findings and to answer CMS’s questions, which was held June 1, 2023.

Global Acoustic Wave Sensors Market Research Report 2023-2030 - Bulk Acoustic Wave Sensors Maintain Their Prominence in Various Applications

Retrieved on: 
Saturday, December 2, 2023

DUBLIN, Dec. 1, 2023 /PRNewswire/ -- The "Acoustic Wave Sensors - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Dec. 1, 2023 /PRNewswire/ -- The "Acoustic Wave Sensors - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
  • The report provides valuable insights into the influencer market and global market trajectories.
  • It introduces acoustic wave sensors, categorizing them into Surface Acoustic Wave (SAW) Sensors and Bulk Acoustic Wave (BAW) Sensors.
  • Growth in the Bulk Acoustic Wave (baw) Sensor segment is estimated at 9.7% CAGR for the next 8-year period.